Vascular endothelial growth factor polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7160991
SERIAL NO

09238088

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to an isolated molecule having vascular endothelial growth factor-like properties and to a genetic sequence encoding same. The molecule will be useful in the development of a range of therapeutics and diagnostics useful in the treatment, prophylaxis and/or diagnosis of conditions requiring enhanced or diminished vasculature and/or vascular permeability. The molecule of the present invention is also a useful effector of primary and central neurons and is capable of inducing astroglial proliferation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LICENTIA LTDTUKHOLMANKATU 8 A HELSINKI FI-00290
LUDWIG INSTITUTE FOR CANCER RESEARCHZURICH SUI ZURICH ZURICH

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grimmond, Sean Taringa, AU 5 0
Hayward, Nicholas Kim Paddington, AU 5 0
Larsson, Catharina Stockholm, SE 7 17
Nordenskjold, Magnus Stockholm, SE 4 0
Weber, Gunther Stockholm, SE 40 287

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation